MPO and Bloom syndrome: On the second day of BLM administration, ELISA analysis showed that the inflammatory mediators IL‐1β (Fig. 2A) and IL‐6 (Fig. 2B), the MCP‐1 (Fig. 2C), the MPO activity (Fig. 2D) were significant increased than control group (P < 0.001).